Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients-Reference-Cited by-同舟云学术

Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients

Published:2011-10-08 Issue:4 Volume:155 Page:498-508
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Gobert Delphine,Bussel James B.,Cunningham-Rundles Charlotte,Galicier Lionel,Dechartres Agnès,Berezne Alice,Bonnotte Bernard,DeRevel Thierry,Auzary Christophe,Jaussaud Roland,Larroche Claire,LeQuellec Alain,Ruivard Marc,Seve Pascal,Smail Amar,Viallard Jean-François,Godeau Bertrand,Hermine Olivier,Michel Marc

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.08880.x/fullpdf

Reference32 articles.

1. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura;Arnold;Annals of Internal Medicine,2007

2. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study;Boileau;Journal of Autoimmunity,2011

3. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect;Bussel;Blood,1991

4. Efficacy and safety of rituximab in adults’ warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases;Bussone;American Journal of Hematology,2009

5. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis;Cambridge;Arthritis & Rheumatism,2003

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The common variable immunodeficiency IgM repertoire narrowly recognizes erythrocyte and platelet glycans;Journal of Allergy and Clinical Immunology;2024-09

2. Clinical and experimental treatment of primary humoral immunodeficiencies;Clinical and Experimental Immunology;2024-02-02

3. Clinical efficacy of anti-CD20 antibodies in autoimmune diseases;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

4. Common Variable Immunodeficiency and Selective IgA Deficiency: Focus on Autoimmune Manifestations and Their Pathogenesis;International Journal of Translational Medicine;2023-10-16

5. Mycophenolate Mofetil Use in Pediatric Immune Thrombocytopenia Refractory to First-line Therapy: a Single-center Experience;Journal of Pediatric Hematology/Oncology;2023-06-05